Search

everythinglearnresearchcommunity

for

Search:↓

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

CD44 variant changes start alopecia areata, but don't maintain it.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Targeting Vδ1+T-cells may help treat alopecia areata.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The article suggests that patients with Frontal Fibrosing Alopecia may have more contact allergies, but it doesn't prove that allergies cause the condition.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Sonic Hedgehog helps keep skin and airway barriers healthy and reduces inflammation.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.